A groundbreaking study led by Professor Takuya Takahashi reveals a significant connection between elevated AMPA receptor density and cognitive symptoms in Long COVID patients. This finding could lead to new diagnostic and treatment strategies.
A groundbreaking blood test cleared by the FDA offers a new way to diagnose Alzheimer's disease, improving accuracy and accessibility for millions. Experts believe this innovation will enhance patient care and early intervention.
